These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 9410127)

  • 61. Management and preparedness for infusion and hypersensitivity reactions.
    Lenz HJ
    Oncologist; 2007 May; 12(5):601-9. PubMed ID: 17522249
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Case reports: type I hypersensitivity to lidocaine.
    Haugen RN; Brown CW
    J Drugs Dermatol; 2007 Dec; 6(12):1222-3. PubMed ID: 18189063
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Allergy in adverse drug reactions.
    Kreithen H
    Semin Drug Treat; 1973; 2(4):431-44. PubMed ID: 4574209
    [No Abstract]   [Full Text] [Related]  

  • 64. Clopidogrel desensitization: case report and review of published protocols.
    Owen P; Garner J; Hergott L; Page RL
    Pharmacotherapy; 2008 Feb; 28(2):259-70. PubMed ID: 18225971
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evaluation of immediate allergic reactions to cephalosporins in non-penicillin-allergic patients.
    Somech R; Weber EA; Lavi S
    Int Arch Allergy Immunol; 2009; 150(3):205-9. PubMed ID: 19494517
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Insulin allergy in clinical practice.
    Skelly AH; Van Son AR
    Nurse Pract; 1987 Apr; 12(4):14-8, 23. PubMed ID: 3554035
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Clinical aspects of allergic reactions to insulin].
    Dreval' AV
    Sov Med; 1977 Jun; (6):112-6. PubMed ID: 897763
    [No Abstract]   [Full Text] [Related]  

  • 68. Cutaneous insulin allergy responsive to oral desensitisation and aspirin.
    Holdaway IM; Wilson JD
    Br Med J (Clin Res Ed); 1984 Dec; 289(6458):1565-6. PubMed ID: 6439319
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Adverse drug reactions: types and treatment options.
    Riedl MA; Casillas AM
    Am Fam Physician; 2003 Nov; 68(9):1781-90. PubMed ID: 14620598
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Clinical examination of challenge test to local anesthetics].
    Yamaguchi T; Nakagome K; Udagawa K; Takaku Y; Sato N; Soma T; Hagiwara K; Kanazawa M; Nagata M
    Arerugi; 2009 Jun; 58(6):657-64. PubMed ID: 19571659
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Adverse events to nontargeted and targeted chemotherapeutic agents: emphasis on hypersensitivity responses.
    Baldo BA; Pagani M
    Immunol Allergy Clin North Am; 2014 Aug; 34(3):565-96, viii. PubMed ID: 25017678
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Questionnaire-based survey of lifetime-prevalence and character of allergic drug reactions in German children.
    Lange L; Koningsbruggen SV; Rietschel E
    Pediatr Allergy Immunol; 2008 Nov; 19(7):634-8. PubMed ID: 18221471
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Practical aspects of choosing an antibiotic for patients with a reported allergy to an antibiotic.
    Robinson JL; Hameed T; Carr S
    Clin Infect Dis; 2002 Jul; 35(1):26-31. PubMed ID: 12060871
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Allergic drug reactions: identification and management.
    Guill MF
    Hosp Formul; 1991 Jul; 26(7):582-4, 587-9. PubMed ID: 10183505
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Insulin allergy desensitization with simultaneous intravenous insulin and continuous subcutaneous insulin infusion.
    Neville KA; Verge CF; Wainstein BK; Woodhead HJ; Ziegler JB; Walker JL
    Pediatr Diabetes; 2008 Aug; 9(4 Pt 2):420-2. PubMed ID: 18775000
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management.
    Hesterberg PE; Banerji A; Oren E; Penson RT; Krasner CN; Seiden MV; Wong JT
    J Allergy Clin Immunol; 2009 Jun; 123(6):1262-7.e1. PubMed ID: 19501233
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Oral challenge in patients with suspected cutaneous adverse drug reactions: findings in 784 patients during a 25-year-period.
    Lammintausta K; Kortekangas-Savolainen O
    Acta Derm Venereol; 2005; 85(6):491-6. PubMed ID: 16396795
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Drug allergy diagnosis.
    Chiriac AM; Demoly P
    Immunol Allergy Clin North Am; 2014 Aug; 34(3):461-71, vii. PubMed ID: 25017672
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Delayed Cutaneous Hypersensitivity Reactions to Antibiotics: Management with Desensitization.
    McNulty CMG; Park MA
    Immunol Allergy Clin North Am; 2017 Nov; 37(4):751-760. PubMed ID: 28965638
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Systemic and local reactions of bee venom immunotherapy in Iran.
    Bemanian MH; Farhoudi A; Pourpak Z; Gharagozlou M; Movahedi M; Nabavi M; Mozafari H; Mohammadzadeh I; Chavoshzadeh Z; Shirkhoda Z
    Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):203-6. PubMed ID: 18094443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.